The endoplasmic reticulum (ER) is an organelle with remarkable plasticity, capable of rapidly changing its structure to accommodate different functions based on intra- and extracellular cues. One of the ER structures observed in plants is known as "organized smooth endoplasmic reticulum" (OSER), consisting of symmetrically stacked ER membrane arrays. In plants, these structures were first described in certain specialized tissues, e.g. the sieve elements of the phloem, and more recently in transgenic plants overexpressing ER membrane resident proteins. To date, much of the investigation of OSER focused on yeast and animal cells but research into plant OSER has started to grow. In this update, we give a succinct overview of research into the OSER phenomenon in plant cells with case studies highlighting both native and synthetic occurrences of OSER. We also assess the primary driving forces that trigger the formation of OSER, collating evidence from the literature to compare two competing theories for the origin of OSER: that OSER formation is initiated by oligomerizing protein accumulation in the ER membrane or that OSER is the result of ER membrane proliferation. This has long been a source of controversy in the field and here we suggest a way to integrate arguments from both sides into a single unifying theory. Finally, we discuss the potential biotechnological uses of OSER as a tool for the nascent plant synthetic biology field with possible applications as a synthetic microdomain for metabolic engineering and as an extensive membrane surface for synthetic chemistry or protein accumulation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892044 | PMC |
http://dx.doi.org/10.1104/pp.20.00719 | DOI Listing |
Struct Equ Modeling
February 2024
We present a bias-adjusted three-step estimation approach for multilevel latent class models (LC) with covariates. The proposed approach involves (1) fitting a single-level measurement model while ignoring the multilevel structure, (2) assigning units to latent classes, and (3) fitting the multilevel model with the covariates while controlling for measurement error introduced in the second step. Simulation studies and an empirical example show that the three-step method is a legitimate modeling option compared to the existing one-step and two-step methods.
View Article and Find Full Text PDFSemin Intervent Radiol
August 2024
Division of Vascular and Interventional Radiology, Department of Radiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Vascular malformations (VMs) are a heterogeneous group of arterial, venous, capillary, and/or lymphatic networks that typically are present at birth and grow with the patient. Signs and symptoms associated with VM range from absent to severe, with a broad spectrum of pain, cosmetic disfigurement, and local tissue destruction. Treatment options for these malformations extend from observation to surgical reconstruction.
View Article and Find Full Text PDFSSM Qual Res Health
June 2024
University of Kentucky, College of Medicine, USA.
J Diabetes Sci Technol
November 2024
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Background: Older adults may be less comfortable with continuous glucose monitoring (CGM) technology or require additional education to support use. The Virtual Diabetes Specialty Clinic study provided the opportunity to understand glycemic outcomes and support needed for older versus younger adults living with diabetes and using CGM.
Methods: Prospective, virtual study of adults with type 1 diabetes (T1D, N = 160) or type 2 diabetes (T2D, N = 74) using basal-bolus insulin injections or insulin pump therapy.
J Am Board Fam Med
October 2024
From the Department of Family Medicine, University of Colorado Anschutz Medical Campus Aurora, CO; American Academy of Family Physicians National Research Network, Leawood, KS.
Background: Continuous glucose monitoring (CGM) for patients with type 1 and type 2 diabetes is associated with improved clinical, behavioral, and psychosocial patient health outcomes and is part of the American Diabetes Association's Standards of Medical Care. CGM prescription often takes place in endocrinology practices, yet 50% of adults with type 1 diabetes and 90% of all people with type 2 diabetes receive their diabetes care in primary care settings. This study examined primary care clinicians' perceptions of barriers and resources needed to support CGM use in primary care.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!